Document is current

Any future updates will be listed below

Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy

Crossref DOI link: https://doi.org/10.1186/s13046-024-03183-9

Published Online: 2024-09-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark